Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Chubb
Cantor Fitzgerald
Deloitte
Mallinckrodt
Express Scripts
Covington
Daiichi Sankyo
Colorcon

Generated: May 23, 2018

DrugPatentWatch Database Preview

MEPERIDINE AND ATROPINE SULFATE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Meperidine And Atropine Sulfate patents expire, and when can generic versions of Meperidine And Atropine Sulfate launch?

Meperidine And Atropine Sulfate is a drug marketed by Wyeth Ayerst and is included in one NDA.

The generic ingredient in MEPERIDINE AND ATROPINE SULFATE is atropine sulfate; meperidine hydrochloride. There are twenty-three drug master file entries for this compound. Additional details are available on the atropine sulfate; meperidine hydrochloride profile page.
Summary for MEPERIDINE AND ATROPINE SULFATE
Drug patent expirations by year for MEPERIDINE AND ATROPINE SULFATE

US Patents and Regulatory Information for MEPERIDINE AND ATROPINE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst MEPERIDINE AND ATROPINE SULFATE atropine sulfate; meperidine hydrochloride INJECTABLE;INJECTION 085121-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst MEPERIDINE AND ATROPINE SULFATE atropine sulfate; meperidine hydrochloride INJECTABLE;INJECTION 085121-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst MEPERIDINE AND ATROPINE SULFATE atropine sulfate; meperidine hydrochloride INJECTABLE;INJECTION 085121-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Healthtrust
Moodys
Argus Health
Boehringer Ingelheim
Daiichi Sankyo
Accenture
Baxter
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.